Icagen, Inc.

Icagen, Inc.

Icagen, Inc. company was founded in 1992 and is based in Durham, North Carolina. Icagen, Inc. (Icagen) is a biopharmaceutical company focused on the discovery, development and commercialization of orally-administered small molecule drugs that modulate ion channel targets. The Company’s programs include ICA-105665 for epilepsy and neuropathic pain, for which the Company is conducting a Phase I multiple ascending dose study in healthy volunteers and epilepsy patients and Senicapoc, previously referred to as ICA-17043, for asthma, for which the Company is conducting two Phase II proof-of-concept clinical trials.

Contact Details

Office Address

Icagen, Inc.
4222 Emperor Blvd., Suite 350
Durham, NC, USA 27703
Phone: (919) 941-5206
Fax: (919) 941-0813

Executives

Co-Founder & Chief Exec. Officer

Dr. P. Kay Wagoner

Chief Financial Officer

Dr. Richard D. Katz

Business Reviews for Icagen, Inc.

Related Companies